170 related articles for article (PubMed ID: 16550733)
1. Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol.
van Giersbergen PL; Halabi A; Dingemanse J
Int J Clin Pharmacol Ther; 2006 Mar; 44(3):113-8. PubMed ID: 16550733
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
[TBL] [Abstract][Full Text] [Related]
3. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
4. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
5. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
6. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
Scheffler MR; Colburn W; Kook KA; Thomas SD
Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
[TBL] [Abstract][Full Text] [Related]
8. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
Sinofsky FE; Pasquale SA
Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
[TBL] [Abstract][Full Text] [Related]
9. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
Doose DR; Wang SS; Padmanabhan M; Schwabe S; Jacobs D; Bialer M
Epilepsia; 2003 Apr; 44(4):540-9. PubMed ID: 12681003
[TBL] [Abstract][Full Text] [Related]
10. Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.
Spence R; Mandagere A; Walker G; Dufton C; Boinpally R
Clin Drug Investig; 2010; 30(5):313-24. PubMed ID: 20384387
[TBL] [Abstract][Full Text] [Related]
11. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
12. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.
Kuhnz W; Heuner A; Hümpel M; Seifert W; Michaelis K
Contraception; 1997 Dec; 56(6):379-85. PubMed ID: 9494772
[TBL] [Abstract][Full Text] [Related]
13. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.
Ouellet D; Hsu A; Qian J; Locke CS; Eason CJ; Cavanaugh JH; Leonard JM; Granneman GR
Br J Clin Pharmacol; 1998 Aug; 46(2):111-6. PubMed ID: 9723818
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol.
Saperstein S; Edgren RA; Lee GJ; Jung D; Fratis A; Kushinsky S; Mroszczak E; Dorr A
Contraception; 1989 Nov; 40(5):581-90. PubMed ID: 2612166
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Formation of Ethinylestradiol After Intramuscular Administration of Norethisterone Enantate.
Friedrich C; Berse M; Klein S; Rohde B; Höchel J
J Clin Pharmacol; 2018 Jun; 58(6):781-789. PubMed ID: 29522253
[TBL] [Abstract][Full Text] [Related]
16. Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive.
Reyes M; Brossard P; Chassard D; Hoch M; Dingemanse J
Eur J Clin Pharmacol; 2014 Mar; 70(3):287-93. PubMed ID: 24362488
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of interaction between fluconazole and an oral contraceptive in healthy women.
Hilbert J; Messig M; Kuye O; Friedman H
Obstet Gynecol; 2001 Aug; 98(2):218-23. PubMed ID: 11506836
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.
LoRusso PM; Piha-Paul SA; Mita M; Colevas AD; Malhi V; Colburn D; Yin M; Low JA; Graham RA
Cancer Chemother Pharmacol; 2013 Jan; 71(1):193-202. PubMed ID: 23064958
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir.
Garg V; van Heeswijk R; Yang Y; Kauffman R; Smith F; Adda N
J Clin Pharmacol; 2012 Oct; 52(10):1574-83. PubMed ID: 22039291
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
Lin WH; Feng HP; Shadle CR; O'Reilly T; Wagner JA; Butterton JR
Eur J Clin Pharmacol; 2014 Sep; 70(9):1107-13. PubMed ID: 24992979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
